The Best Fintech Stocks to Buy With $500 Right Now

Affirm reported 25.8M active consumers and 478K active merchants (up from 21M and 337K a year earlier); analysts project revenue and adjusted EBITDA CAGRs of 26% and 132% from FY2025–FY2028, and the company trades at an enterprise value of $18B (~16x this year's adjusted EBITDA). Chime served 9.5M active members at end-2025 (+19% YoY); analysts forecast revenue and adjusted EBITDA CAGRs of 19% and 92% through 2028, and Chime trades at an EV of $7.6B (~19x this year's adjusted EBITDA) while monetizing via card swipe cuts and partner-bank relationships.

Analysis

The fintech winners over the next 12–36 months will be those that convert transactional flows into proprietary credit and data moats while keeping funding elastic. Merchant-facing BNPL players that also own underwriting and securitization flows can expand EBITDA far faster than pure interchange collectors because each incremental transaction leverages fixed servicing costs and creates assets that can be funded off-balance-sheet; but that path is highly sensitive to funding spreads and ABS investor appetite, which can re-rate multiples quickly if rates widen or loss assumptions change.

Churn of cash-deprived consumers into neo-banks shifts a different set of economics: it lowers core deposit beta for incumbents but concentrates credit and deposit risk with platform partners. When deposit custody is outsourced to partner banks, product economics become a three-way negotiation (platform, partner bank, card network) — any renegotiation of fee splits or regulatory constraints on interchange/share agreements is a single-event risk that can reset revenue curves within quarters.

Competitor responses and regulation are the most underpriced vectors. Card networks and large tech players can replicate installment rails and bundle them into broader ecosystems, compressing merchant economics and forcing BNPL players either to move upmarket into higher-margin products or to expand into savings/credit products where cross-sell economics are real. The cleanest way to express the next 12–24 month upside is via structures that capture asymmetric gains from continued penetration while protecting against macro-driven credit shocks or regulatory repricing.

Key Decisions for Investors

• Long AFRM via a 12–18 month call spread (buy 1.0-year ITM/near-ATM call, sell a call ~30–50% OTM) sized 2–4% of portfolio. Rationale: captures EBITDA multiple expansion tied to continued merchant penetration while capping premium paid; treat max loss = premium, target 1.5x–3x payoff if BNPL share trajectory remains intact.
• Relative pair: dollar-neutral long AFRM / short V over 12–24 months (small notional, 0.5–1.5% net exposure). Rationale: asymmetric bet that merchant economics reallocate share from interchange to platform fees; hedge with a 12-month stop if AFRM misses fundamentals or if V reports durable margin tailwinds. Target scenario: AFRM >+50% / V -10–20% → strong net payoff.
• Accumulate CHYM equity tactically (1–2% position) and buy a 9–12 month protective put ~20–30% OTM sized to 20–25% of the position. Rationale: secular deposit acquisition story with notable counterparty/partner-bank execution risk — protect the downside while keeping upside optionality if low-income monetization continues.
• Portfolio tail hedge: purchase 12-month puts on consumer-finance indices or buy 12-month puts on AFRM sized to cover ~10% of long fintech exposure. Rationale: protects against a macro-driven spike in consumer delinquencies or a sudden ABS funding squeeze that would reprice all BNPL and neo-bank equities within weeks.